A REDUCTION IN TIME WITH ELECTRONIC MONITORING IN STROKE TRIAL (ARTEMIS Trial).
Completed
- Conditions
- Strokebrain infarction10007963
- Registration Number
- NL-OMON46211
- Lead Sponsor
- eurologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
All patients with suspected stroke potentially eligible for IVT and/or IAT for whom the dispatch office send out an ambulance.
Exclusion Criteria
younger than 18 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>TSD to IAT and TSD to IVT. </p><br>
- Secondary Outcome Measures
Name Time Method <p>- the proportion of patients finally treated with IVT /IAT calculated from:<br /><br>- the total of patients for whom the ambulance issues a dispatch<br /><br>- the total of patients transferred to the hospital with suspected stroke<br /><br>- the total of patients with a final diagnosis of (ischemic) stroke<br /><br>- functional outcome at three-months measured by telephone with the modified<br /><br>Rankin scale</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of electronic monitoring in improving stroke outcomes in NL-OMON46211?
How does electronic monitoring compare to standard-of-care in acute ischemic stroke management?
Which biomarkers are associated with response to electronic monitoring in brain infarction patients?
What adverse events are reported with electronic monitoring in stroke trials and how are they managed?
Are there combination approaches or competitor drugs to electronic monitoring for stroke recovery?